Compare Agilent Technologies Inc (A) vs Grab Holdings Ltd. (GRAB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Grab Holdings Ltd. — how do they compare? Agilent Technologies Inc trades at $128.24 (market cap $37.04B), while Grab Holdings Ltd. trades at $3.82 (market cap $16.07B). The key difference: Agilent Technologies Inc is far larger — about 2.3× Grab Holdings Ltd.'s market cap, and Agilent Technologies Inc pays a 0.78% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals.
| A | GRAB | |
|---|---|---|
Market Cap | $37.04B | $16.07B |
Sector | Health | Technology |
52-Week High | $157.20 | $6.45 |
52-Week Low | $110.24 | $3.27 |
Enterprise Value | $38.59B | $11.77B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
GRAB trades at $3.93, up 0.77% today, with a bullish technical signal from moving averages. The company achieved profitability in 2025 with net income of $268 million and revenue growth to $3.37 billion. Recent news highlights the departure of Uber's CEO from GRAB's board, causing a brief stock dip. Analyst consensus is strongly bullish with a $5.60 price target, representing significant upside potential from current levels.
GRAB's outlook is positive due to sustained revenue growth and recent profitability, though high P/E of 96.25 suggests elevated expectations. Key risks include competitive pressures in Southeast Asia and reliance on continued user growth. The stock offers growth exposure to the region's digital economy, supported by strong analyst buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →
